Latest 10-K annual reports

NASDAQ
Identiv, Inc. has filed an amendment to its 2025 Annual Report on Form 10-K, primarily to include Part III information regarding directors, executive compensation, and corporate governance.
NASDAQ
Creative Media & Community Trust Corporation files Amendment No. 1 to its 2025 Form 10-K to include previously omitted Part III information regarding directors, executive compensation, and related party transactions.
Monroe Capital Corporation files an amendment to its 2025 10-K, detailing its merger with Horizon Technology Finance Corporation and subsequent termination of SEC reporting obligations.
NASDAQ
Medicus Pharma Ltd. has filed an amendment to its 2025 Form 10-K, primarily to include previously omitted Part III information regarding directors, executive compensation, and corporate governance.
Q/C Technologies, Inc. has filed an amendment to its 2025 Form 10-K to include previously omitted Part III information regarding directors, executive officers, compensation, and related matters.
NYSE
Braemar Hotels & Resorts Inc. files Amendment No. 1 to its Annual Report on Form 10-K for the fiscal year ended December 31, 2025, to include previously omitted information in Part III and updated certifications.
NASDAQ
Nutriband Inc. filed its annual report for the fiscal year ended January 31, 2026, detailing progress on its AVERSA Fentanyl abuse-deterrent transdermal system and financial performance from its contract manufacturing segment.
Stablecoin Development Corporation (formerly NovaBay Pharmaceuticals, Inc.) is restating its 2025 financial statements due to an accounting error related to common stock warrants, impacting warrant liability by $608.6 million.
NYSE
Howard Hughes Holdings Inc. has filed an amendment to its 2025 annual report to include previously omitted Part III information regarding directors, executive compensation, and corporate governance.
NASDAQ
Shopify Inc. has filed an amendment to its 2025 Form 10-K to include Part III information and updated certifications.
OQB
Viskase Holdings, Inc. (formerly Enzon Pharmaceuticals, Inc.) has filed an amendment to its 2025 Form 10-K to include required Part III information, detailing corporate governance, executive compensation, and related party transactions following its merger with Viskase Companies.
NYSE
Kennedy-Wilson Holdings, Inc. files Amendment No. 1 to its 2025 Form 10-K to include previously omitted Part III information regarding directors, executive officers, corporate governance, and executive compensation.
NASDAQ
Senti Biosciences Holdings, Inc. has filed an amendment to its 2025 annual report, providing detailed information on its directors, executive officers, corporate governance, and executive compensation.
NYSE
Enviri Corporation has filed an amendment to its 2025 Annual Report on Form 10-K to include previously omitted Part III information.
NASDAQ
United Homes Group, Inc. has filed an amendment to its 2025 Form 10-K, primarily to include previously omitted Part III information and new executive certifications.
Pantages Capital Acquisition Corporation files an amendment to its 2025 10-K report to correct certifications regarding internal controls.
NASDAQ
Sadot Group Inc. disclosed substantial operational issues and significant financial losses for the fiscal year ended December 31, 2025, leading to a drastic reduction in commodity sales and a negative working capital position.
NASDAQ
XBiotech Inc. has filed an amendment to its 2025 Form 10-K, primarily to include previously omitted Part III information regarding directors, executive officers, and corporate governance.
OTC.Pink
Nu Ride Inc. (formerly Lordstown Motors Corp.) has filed an amendment to its 2025 Form 10-K to include Part III information, detailing directors, executive compensation, and corporate governance.
NASDAQ
Ultralife Corporation has filed an amendment to its Form 10-K for the fiscal year ended December 31, 2025, to include omitted Part III information.
NASDAQ
NRC Health filed an amendment to its 2025 Annual Report to provide required director and executive compensation disclosures.
NASDAQ
BioLife Solutions files an amendment to its 2025 Annual Report to provide updated disclosures regarding corporate governance, executive compensation, and director information.
AMEX
Nuburu, Inc. filed an amendment to its 2025 Annual Report to provide required Part III disclosures and updated certifications.
NASDAQ
BGC Group, Inc. has filed an Amendment No. 1 to its Annual Report on Form 10-K for the fiscal year ended December 31, 2025, primarily to include omitted Part III information.
NASDAQ
Black Hawk Acquisition Corporation has filed an amendment to its 2025 annual report, primarily to include its adopted Compensation Recovery (Clawback) Policy.
NASDAQ
FTC Solar, Inc. has filed an amendment to its 2025 Annual Report on Form 10-K to include previously omitted Part III information, along with updated executive certifications.
AMEX
Nine Energy Service, Inc. files Amendment No. 1 to its Annual Report on Form 10-K for the fiscal year ended December 31, 2025, to include previously omitted Part III information and updated certifications.
NASDAQ
PDS Biotechnology Corporation has filed an amendment to its 2025 Annual Report on Form 10-K, primarily to include Part III disclosures regarding directors, executive officers, compensation, and related matters.
NASDAQ
XCF Global, Inc. has filed an amendment to its 2025 Form 10-K, primarily to include Part III information regarding directors, executive compensation, and corporate governance.
NASDAQ
AnaptysBio amends its 2025 annual report to include details on board composition changes, executive compensation, and related party transactions.